<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95758">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01886456</url>
  </required_header>
  <id_info>
    <org_study_id>14.1.2013_KEK ZH 2012-0422</org_study_id>
    <nct_id>NCT01886456</nct_id>
  </id_info>
  <brief_title>IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients</brief_title>
  <official_title>Effect of Patterned Laser Trabeculoplasty on Intraocular Pressure Compared to Selective Laser Trabeculoplasty in Treatment Naiv Patients Suffering From Open-angle Glaucoma or Ocular Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect of patterned laser trabeculoplasty (PLT) compared to selective
      laser trabeculoplasty (SLT) on intraocular pressure (IOP) in treatment naiv patients
      suffering from open-angle glaucoma or ocular hypertension.

      Values for IOP will be measured at baseline, 1 day and 1 month post-interventional as well
      as 2, 3, 6, 9, 12, 18 and 24 months after treatment.

        -  Trial with medical device
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Intraocular pressure 6 months after Intervention</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Open Angle Glaucoma,</condition>
  <condition>Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>PLT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients treated with patterned laser trabeculoplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SLT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients treated with selective laser trabeculoplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser trabeculoplasty</intervention_name>
    <arm_group_label>PLT</arm_group_label>
    <arm_group_label>SLT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Intraocular pressure (treatment naiv or after 4 weeks wash-out phase) &gt; 21 mm Hg

          -  visible angle structures over 360Â° on gonioscopy

          -  age = 18 years

        Exclusion criteria:

          -  Intraocular Inflammation

          -  patients who underwent refractive corneal surgery for any reason or who underwent
             ocular surgery to reduce intraocular pressure (e.g. trabeculectomy)

          -  monocle situation

          -  anterior chamber lenses (incl. iris claw)

          -  secondary glaucoma (with the exception of pseudoexfoliation and pigment dispersion)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Kniestedt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Ophthalmology Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gregor Jaggi, MD</last_name>
    <email>gregor.jaggi@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph Kniestedt, MD</last_name>
    <email>christoph.kniestedt@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich, Ophthalmology Clinic</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 24, 2013</lastchanged_date>
  <firstreceived_date>June 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
